Twelve-lead ECGs, although standard in hospitals, can be bulky and impractical for home use. On the other hand, Apple Watch’s ECG app is easy to use, but it is limited in what it can detect because it ...

HeartBeam (NASDAQ: BEAT) a medical technology company focused on transforming cardiac care by providing powerful ...

The company says its machine learning approach could help flag cardiac amyloidosis from standard 12-lead ECGs, though experts ...

Belgrade, Serbia, May 11th, 2026, FinanceWireHeartBeam (NASDAQ: BEAT) announced the initiation of a pilot study ...

AliveCor has spent years battling with Apple over the market for consumer heart monitoring technology. Now it’s hoping to make its imprint on professional health care with its new device, which ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced it ...

HeartBeam (NASDAQ: BEAT) a medical technology company focused on transforming cardiac care by providing powerful cardiac ...

Ambulatory patch device designed to aid in detecting ischemia and complex arrythmias Targets a $2 billion market with established reimbursement; ischemia detection has potential to disrupt the patch ...

The 12-lead ECG hasn't changed in a century. The algorithms reading it have. Three CEOs and one educator on whether doctors ...

HeartBeam said its study data advances the scientific foundation supporting a planned indication expansion of its ECG device ...